1. S


    Hi All, I know that the FDA will be deciding what to do about Endaravone in June 2017 here in the US, but I'm wondering, do any of you know how I could research where we could potentially go in Japan to have access to Endaravone sooner than that? I imagine that even if the FDA approves, the...
  2. R

    Edaravone ( Radicut, Radicava ) Action Needed - Possible Access Program

    Important action item! There are indications that MT Pharma America (Mitsubishi Tanabe) may well be willing to set up an early access program for edaravone for people with ALS. It's very important that they hear from people to let them know that this would be used and appreciated. Here is...
  3. S

    Advice for brother newly diagnosed with ALS

    Hello all, my brother was diagnosed 2 weeks ago with ALS. He's 40 with a pregnant wife and a toddler. His diagnosis took about 15 months from first symptom - a fall. He now has a finger that doesn't work, an arm muscle that doesn't work, some weakness, twitches, and some spasticity. He also has...
  4. G

    FDA Accepts Filing of ALS Drug EdaravonE

    I noted this ~3 months back, but it got more press. The FDA has accepted the New Drug Application (NDA) for edaravone (MCI-186) to treat amyotrophic lateral sclerosis (ALS). The PDUFA date — the day when a decision on the application is expected — is June 16, 2017. FDA Accepts Filing of ALS...
  5. G


    Currently being used in Japan. Mitsubishi Tanabe Pharma Corporation has submitted a New Drug Application. Mitsubishi Tanabe Pharma Submits New Drug Application for Edaravone to Treat ALS in the United States This is also known as MCI-186, and is being worked by Treeway.
  6. G


    Interesting. This outfit has 3 ALS treatments in the pipeline. Treeway Pipeline - Treeway One, TW001, is a mod of the recent drug approved in Japan, edaravone. They state it should hit the market in 2017. Treeway’s pipeline is anchored on the role of immunology and inflammation in the disease...
  7. indigosd


    Just found this and wondered if anyone else has read, seen or heard about this study and what it means? Exp Neurol. 2008 Oct;213(2):448-55. Epub 2008 Jul 31. Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice. Ito H, Wate R...